Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research

The Lancet Oncology · Published 2026-07-27 · DOI 10.1016/s1470-2045(26)00215-9

Authors (28)

Babita Kataria, Asima Mukhopadhyay, Ana Oaknin, Dearbhaile M O'Donnell, David S P Tan, David Cibula, Maaike C G Bleeker, Marie Plante, Cyrus Chargari, Alison Brand, Domenica Lorusso, Jyoti Mayadev, Alexandra Leary, Kosei Hasegawa, Elise C Kohn, Lucas C Mendez, Patrick J Maguire, Carmen Garcia-Duran, Kim Hanly, Parul Malhotra, Linda Emery, Margaret Happy, Remi A Nout, Fabrice Lecuru, Allan Covens, Gavin C E Stuart, Amit M Oza, Michael A Bookman

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Kataria, B., Mukhopadhyay, A., Oaknin, A., et al. (2026). Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(26)00215-9

Related articles

• Small Cell and Other Rare Histologic Types of Cervical Cancer · Current Oncology Reports · 2022 · Cites or is cited by this article
• A step forward for precision oncology in thyroid cancer · The Lancet Oncology · 2026 · Same journal
• RCP calls for UK to recognise air pollution as a public health emergency · The Lancet Oncology · 2026 · Same journal
• French MPs vote for sharp cuts in cadmium content in fertilisers · The Lancet Oncology · 2026 · Same journal
• The intermediate-risk gap in AI-based breast cancer stratification · The Lancet Oncology · 2026 · Same journal
• Perioperative systemic therapy versus surgery alone for resectable colorectal peritoneal-only metastases (CAIRO6): a randomised, open-label, phase 3 trial · The Lancet Oncology · 2026 · Same journal
• Gastric cancer with peritoneal metastases: hype or hope for HIPEC? · The Lancet Oncology · 2026 · Same journal
• Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS) · The Lancet Oncology · 2026 · Same journal
• Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre study · The Lancet Oncology · 2026 · Same journal
• Radiotherapy dose escalation in glioblastoma: the thin ice of of historical controls · The Lancet Oncology · 2026 · Same journal